Dr. Goy on Next Steps With CAR T-Cell Therapy in MCL
Andre Goy, MD, discusses the next steps with CAR T-cell therapy in mantle cell lymphoma.
Dr. Goy on CAR T-Cell Therapy Updates in Non-Hodgkin Lymphoma
Andre Goy, MD, MS, chief, Division of Lymphoma, chairman and director, John Theurer Cancer Center, discusses updates in CAR T-cell therapy that are being presented at the 2019 ASCO Annual Meeting.
Dr. Goy Discusses Intensive Therapy for MCL
Andre Goy, MD, MS, discusses intensive therapy for the treatment of patients with mantle cell lymphoma (MCL).
Dr. Goy on CAR-Modified T Cells in Lymphoma
Andre Goy, MD, MS, from the John Theurer Cancer Center, discusses the apparent effectiveness of CD19-targeted CAR-modified T cells as a treatment for patients with various types of lymphoma.